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Abstract
Background: There is an ongoing debate whether stroke patients presenting with minor or moderate symptoms benefit
from thrombolysis. Up until now, stroke severity on admission is typically measured with the NIHSS, and subsequently used
for treatment decision.
Hypothesis: Acute MRI lesion volume assessment can aid in therapy decision for iv-tPA in minor stroke.
Methods:We analysed 164 patients with NIHSS 0–7 from a prospective stroke MRI registry, the 1000+ study (clinicaltrials.org
NCT00715533). Patients were examined in a 3 T MRI scanner and either received (n = 62) or did not receive thrombolysis
(n = 102). DWI (diffusion weighted imaging) and PI (perfusion imaging) at admission were evaluated for diffusion - perfusion
mismatch. Our primary outcome parameter was final lesion volume, defined by lesion volume on day 6 FLAIR images.
Results: The association between t-PA and FLAIR lesion volume on day 6 was significantly different for patients with smaller
DWI volume compared to patients with larger DWI volume (interaction between DWI and t-PA: p = 0.021). Baseline DWI
lesion volume was dichotomized at the median (0.7 ml): final lesion volume at day 6 was larger in patients with large
baseline DWI volumes without t-PA treatment (median difference 3, IQR 20.4–9.3 ml). Conversely, in patients with larger
baseline DWI volumes final lesion volumes were smaller after t-PA treatment (median difference 0, IQR 24.1–5 ml).
However, this did not translate into a significant difference in the mRS at day 90 (p = 0.577).
Conclusion: Though this study is only hypothesis generating considering the number of cases, we believe that the size of
DWI lesion volume may support therapy decision in patients with minor stroke.
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Introduction
Thrombolysis has become standard therapy in the treatment of
acute ischemic stroke and is used within a time frame of #
4.5 hours in Europe since ECASS 3 [1]. However, uncertainty
remains when it comes to treating patients with minor stroke or
rapidly improving symptoms, especially considering the side effects
of t-PA with an increased risk of intracerebral or extracranial
haemorrhages [2].
Moreover, there is disagreement regarding the outcome in
minor stroke patients with reports of excellent outcome at 3
months follow-up without any intervention [3] but also poor
outcome reported in nearly one third when withholding
thrombolysis [4,5].
MRI has been suggested to identify patients with minor stroke
as well as point out those who might suffer a recurrent stroke and
might therefore benefit from thrombolysis. Rajajee et al. [6] and
others [7] found vessel pathology to be predictive for recurrent
stroke in transient ischemic attacks (TIA) and minor stroke patients
as well as for outcome. Vessel pathology was also associated with
clinically beneficial treatment effects. However, the included
patients showed signs of moderate to severe stroke in an extended
time window of ,9 hours from symptom onset to treatment [8].
This leaves minor stroke patients who show no vessel pathology
but are considered as possibly benefitting from thrombolysis.
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It also has been shown that a mismatch volume of more than
10 ml is predictive of lesion progression and early neurological
deterioration [9], though, perfusion imaging cannot always be
obtained for instance due to renal failure.
Furthermore, to save time, especially at the end of the mandated
time window it might be necessary to shorten the MRI imaging
protocol to haemorrhage sensitive sequences (T2*) and diffusion
weighted imaging (DWI).
Therefore, we aimed to evaluate the potential of DWI at
admission in patients with low/moderate NIHSS in facilitating
therapy decision towards thrombolysis by comparing minor stroke
patients who did and did not receive t-PA.
Patients and Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1, Protocol
S1 and Figure 1.
From 11/2008 until 6/2012 we included 190 patients with
ischemic stroke from the observational 1000+ study, registered at
clinicaltrials.org NCT00715533.
Ethics statement
Written informed consent was obtained from all patients. The
study design (1000+ study) was approved by the ethics committee
of the Charite´ - Universita¨tsmedizin, Berlin (EA4/026/08).
Figure 1. CONSORT 2010 Flow Diagram.
doi:10.1371/journal.pone.0110477.g001
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MRI Examination
Data acquisition was performed on a 3 Tesla MRI scanner (Tim
Trio, Siemens AG, Erlangen, Germany). The imaging protocol
included a diffusion weighted imaging (DWI) (TR/TE/FOV/
matrix: 7600 ms/93 ms/230 mm/1926192, slice thickness
2.5 mm, b= 1000 s/mm2, 6 different directions), bolus – track
perfusion imaging (PI) (TR/TE/flip angle/FOV/matrix: 1390
ms/29 ms/60u/230 mm/1286128, slice thickness 5 mm), a fluid-
attenuated inversion recovery sequence (FLAIR) (TR/TE/TI/flip
angle/FOV/matrix: 8000 ms/100 ms/2370.5 ms/130u/
220 mm/2566256, slice thickness 5 mm) and a 3 dimensional
time-of-flight magnetic resonance angiography (MRA) (TR/TE/
flip angle/field of view/slice thickness: 22 ms/3.9 ms/20u/
162*200/0.7 mm). For the perfusion measurements a bolus of
5 ml Gadovist was administered, followed by a saline flush both at
a flow rate of 5 ml/s.
Postprocessing of perfusion images was performed with the
Siemens standard software package resulting in regional cerebral
blood flow (rCBF), regional cerebral blood volume (rCBV) and
mean time-to-peak (MTT) maps with the latter used for further
analysis. Regions of interests (ROI) were manually drawn on DWI,
MTT – maps and FLAIR day 6 images. Lesion volumes were
calculated from ROIs, acute absolute mismatch volume (MTT
volume – DWI volume) and mismatch ratio (MTT volume/DWI
volume) were assessed.
Statistical analysis
All continuous variables were checked for normal distribution
(histogram check, absolute skewness-value ,1) before using
parametric tests. Otherwise non-parametric statistical tests were
applied or the variables were transformed before analysis to reduce
skewness in distribution. The Mann-Whitney test was employed to
compare differences between groups for quantitative non-normally
distributed outcomes. To assess differential treatment ((iv) t-PA)
effects for patients with different DWI volume on admission with
regard to FLAIR volume on day 6, a regression analysis was
performed using log-transformed values for lesion volumes with
log-transformed FLAIR volume as outcome. Log-transformation
was performed to overcome the skewed distributions. A regression
analysis was also used to evaluate the association between vessel
status and FLAIR volumes on day 6. A level of a=0.05 was
considered significant. No adjustment for multiple testing was
applied.
Table 1. Patients characteristics.
n=164 NIHSS 0–7 iv t-PA NIHSS 0–7 non iv t-PA pa
n 62 102
gender (female) n (%) 26 (41.9%) 38 (37.3%) 0.621
age (years) 71 (63–77) 70 (62–78) 0.888
onset – MRI (minutes) 105 (79–147) 233 (122–382) ,0.001
DWI (ml) 0.8 (0.3–3.8) 0.7 (0.2–2.3) 0.279
relMTT (ml) 12.0 (0.3–60.2) 6.4 (0.0–35.9) 0.220
MM volume (ml) 7.1 (20.1–49.8) 3.5 (20.1–34.2) 0.545
MM ratio 3.1 (0.0–24.6) 3.7 (0.0–16.7) 0.939
FLAIR day6 (ml) 3.2 (0.7–7.0) (n = 46) 2.3 (0.6–8.9) (n = 72) 0.623
mRS day 90 1 (0–2) (n = 62) 1 (0–2) (n = 102) 0.577
NIHSS day1 4 (2–5) (n = 62) 2 (1–4) (n = 102) 0.002
NIHSS day6 1 (0–2) (n = 51) 1 (0–2) (n = 88) 0.57
aMann - Whitney for differences in thrombolysis versus non intravenous (iv) t-PA
Age, onset, volumes, NIHSS, mRS are given as median, interquartile range (IQR)
iv t-PA = intravenous tissue plasminogen activator, ml = millilitre, MM = mismatch
doi:10.1371/journal.pone.0110477.t001
Figure 2. Association between DWI volume day 1 and FLAIR
volume day 6.
doi:10.1371/journal.pone.0110477.g002
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For exploratory purposes we used a median split of 0.7 ml to
assess the effect of thrombolysis on DWI and FLAIR volumes. All
statistical analyses were performed using SPSS version 20.
Results
The inclusion criteria for this study were as follows:
Visible lesions on DWI at admission, since it could be
demonstrated that only 4 out of 299 patients with negative DWI
images had perfusion deficits, indicating ischemia [10]. Further
criteria were time interval between symptom onset and MRI
examination #9 hours in view of interventional studies like AXIS
or DIAS III/IV, as well as mild to moderate stroke with NIHSS
up to 7 [11,12] with or without t-PA therapy.
One-hundred-and-sixty-four out of 190 patients with minor/
moderate stroke were considered for further analysis.
The reasons for exclusion were incomplete examinations (n = 7),
faulty entry to database (n = 5), unknown symptom onset (n = 5),
onset.9 hours (n = 4), mechanical thrombus extraction (n= 2), no
visible DWI lesion (n = 1), one haemorrhage and one patient with
postictal edema.
The reasons for patients within the time window of less than
4.5 hours (n = 50) for not receiving t-PA were as follows:
Rapidly improving symptoms (n= 24), patients considered ‘‘too
good’’ to treat (n = 6), infarcts of varying ages (n = 4), oral
anticoagulation (n= 3), haemorrhagic transformation (n = 1), one
patient had occlusions of both vertebral arteries and the basilary
artery, one had a clear demarcation on FLAIR and the last one
had haemoptysis. In 9 patients no further information on the
reasons for exclusion from t-PA therapy could be obtained.
Detailed patient characteristics are given in table 1.
There were no significant differences in baseline variables
between patients treated with iv t-PA and those not treated, with
the exception of time between onset and MRI examination with
shorter delays in treated patients, median:105 minutes (IQR 79–
145 minutes) compared to 233 minutes (IQR 122–380 minutes) in
untreated patients (p,0.001). There was also a difference in
NIHSS values at admission: median NIHSS 4 (IQR 2–5) in iv t-
PA treated patients compared to 2 (IQR 1–4) in the non iv t-PA
group (p= 0.002). No significant difference for mRS at 3 months
follow-up was found between groups (median 1 (IQR 0–2))
(p = 0.577).
Though no significant differences between the median DWI
volume at admission and FLAIR volume on day 6 could be
demonstrated, the regression analysis showed a significant
interaction of DWI volume and thrombolysis on FLAIR day 6
volumes as outcome parameter (p = 0.021) (figure 2, table 2)
indicating differential treatment effects for those with smaller
DWI volumes compared to those with larger DWI volumes. To
further explore this result we performed a median split [13] at
0.7 ml baseline DWI volume and compared infarct growth in
patients who received t-PA and in those who did not (table 3). The
largest increase in lesion volume was found in those patients with
large admission DWI volumes who did not receive t-PA (median
difference: 3.01 ml, IQR: 20.35–9.28 ml). The smallest lesion
growth could be detected in patients with large DWI volume who
received t-PA (median difference: 0 ml, IQR 24.10–5.00 ml)
(figure 3, 4). No significant interaction between vessel status at
baseline and outcome could be demonstrated for either groups (iv
t-PA treated and untreated) (p = 0.928). Analysing both groups
separately those patients with occlusions, not receiving iv t-PA
showed a tendency towards larger FLAIR day 6 volumes
compared to patients with no vessel pathology. Contrary, in
patients with vessel occlusion treated with iv t-PA FLAIR volumes
on day 6 tended to be smaller compared to those without vessel
pathology.
Table 2. Linear regression analysis for FLAIR day 6 (log-tranformed) (n = 118, adjusted r2 = 0.23).
b (se) p
constant 0.35 (0.10) 0.001
NIHSS day 1 (log-transformed) 0.20 (0.13) 0.113
DWI volume (log-transformed) 0.64 (0.13) ,0.001
iv t-PA (versus non iv t-PA) 0.001 (0.13) 0.997
Interaction t-PA*DWI volume 20.44 (0.19) 0.021
Vessel status (reference: no pathology)
occlusion 0.01 (0.14) 0.928
stenosis 20.13 (0.16) 0.416
doi:10.1371/journal.pone.0110477.t002
Table 3. Lesion volume changes of DWI volume and FLAIR day 6 by DWI volume categories and t-PA therapy.
low DWI volume (,0.7 ml) high DWI volume ($0.7 ml)
iv t-PA (n =25) non iv t-PA (n =32) iv t-PA (n=21) non iv t-PA (n=40)
DWI volume (ml) median, interquartile range 0.32 (0.15–0.50) 0.18 (0.04–0.48) 3.60 (1.55–10.70) 2.25 (1.10–4.70)
FLAIR volume day 6 (ml) median, interquartile range 2.1 (0.58–4.92) 0.74 (0.20–2.33) 5.50 (0.80–11.35) 5.85 (2.02–12.03)
Difference FLAIR volume day 6/DWI volume (ml) median,
interquartile range
1.90 (0.33–4.77) 0.39 (0.04–2.15) 0.00 (24.10–5.00) 3.01 (20.35–9.28)
iv = intravenous, n = number, ml = millilitre.
doi:10.1371/journal.pone.0110477.t003
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Discussion
In this pilot study we found a significant association between
infarct volume changes and thrombolytic treatment. Treatment
effect in terms of smaller infarct growth was stronger in patients
with larger DWI volumes compared to those with smaller DWI
volumes. This argues for baseline DWI volume as useful
parameter in assisting therapy decision towards or against
thrombolysis in minor stroke patients.
There is still considerable uncertainty regarding therapy
decision resting upon clinical scales like the NIHSS alone. Many
attempts have been undertaken to assess non-isolated symptoms as
defining variables in minor stroke (NIHSS #6) [14], different
combinations of NIHSS items and cut-offs [15] or defining key
symptoms like language impairment and distal paresis, which may
justify the use of thrombolysis [16].
There have also been many efforts to establish imaging variables
capable of predicting deficit and severity of disability due to stroke,
therefore aiding therapy decisions. Among those the most
common imaging parameter is the perfusion – diffusion mismatch
to detect potentially salvageable tissue. Recently, for minor stroke,
a volume of mismatch above 10 ml was found to be associated
with infarct growth and neurological deterioration [9]. However,
there are often situations which impede or even prevent the
application of contrast media as well as technical problems like
motion artefacts complicating the analysis of perfusion maps. In
more severe stroke, there is evidence, that mismatch severity may
be relevant for selecting patients suitable for thrombolytic
treatment [17] with a mismatch ratio of 2.6 proving the highest
Figure 3. Lesion volume development in minor/moderate stroke after iv t-PA.
doi:10.1371/journal.pone.0110477.g003
Figure 4. Lesion volume development in minor/moderate stroke without therapy.
doi:10.1371/journal.pone.0110477.g004
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sensitivity (90%) and specificity (83%) [18]. In minor stroke this
observation was not yet established, but may also apply.
Other studies describe correlations between acute DWI and PI
lesion volumes and acute and chronic stroke scales [19–21] with
the most powerful predictive parameter for recanalisation being
baseline NIHSS score ,15 and lower absolute TPP. Furthermore
baseline DWI lesion volume was described to be highly correlated
with final infarct size (p,0.0001) on day 60 [22].
Another strong relationship was reported between infarct extent
and location providing a good estimate of neurological deficit
within 3 months of stroke onset [23]. However, for the acute/
subacute phase further evidence is required.
The association between the extent of infarct growth and
outcome in patients with moderate/severe stroke symptoms has
already been proven [24], as well as the contribution of vessel
abnormalities [7]. Though, no attempts have been made to assess
the prediction of DWI baseline infarct volume on outcome in t-PA
treated and untreated minor stroke patients.
As a novel finding in our study, infarct growth was attenuated
by thrombolysis in patients with larger DWI infarcts. However,
within our small cohort the median mRS at day 90 did not differ
significantly in treated and untreated patients, hence, no clear
prediction regarding long term outcome can be drawn. Likewise,
Urra et al., in a study cohort of 203 patients did not find significant
differences in mRS on day 90, but did find a decrease in the mRS
in the ordinal regression analysis [25] indicating an improved long
term outcome too.
The lack of a significant difference in long term outcome may
also be explained by the limited capacity of the mRS in depicting
post stroke disorders like fatigue, depression [26] or cognitive
problems. These symptoms may be just as likely in low NIHSS
stroke patients and can considerably influence quality of life.
Hence, other instruments assessing quality of life are required in
minor stroke patients [27].
We found no association between vessel status and outcome, but
untreated minor stroke patients with vessel occlusions showed, at
least for the short term, an increase in infarct volume compared to
iv t-PA treated patients, therefore pointing to the effect of
thrombolysis. This observation is shared by others [22,28],
however, in cohorts of more severe stroke patients compared to
our study cohort.
The limitation of our study is clearly the small number of
patients, indicating that this study is underpowered to sufficiently
predict long term outcome and thus may be considered as only
hypothesis generating. Using a median split of baseline DWI
volume at 0.7 ml seems to be arbitrary at the moment, however, in
dichotomizing the data the influential effect of t-PA treatment
could be illustrated. Though, using this method a loss or
overestimation of effect size and power in case of bivariate
relationships or analysis of independent variables must be kept in
mind [13]. Moreover, the extended time window of up to 9 hours
after symptom onset may negatively affect lesion volume evolution.
This may account for the large increase in large DWI lesion
volumes in untreated patients. Another source of bias represents
the decision for t-PA treatment based upon clinical reasons alone.
Thus, further prospective studies to support or reject our results
are required.
Conclusions
The size of baseline DWI infarct volumes can support therapy
decision for iv t-PA in minor stroke, in addition to findings of
perfusion imaging and NIHSS score. Though, regarding the
number of cases, this study must be considered as only hypothesis
generating.
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